Abstract
The molecular biology approach in tumor study has been experiencing significant development over last decades and has brought new insights into the pathogenesis of cancer. Some of them are used in practice and introduced directly into oncology care thanks to new technologies.
Molecular biology has enabled the introduction of entirely new cancer treatment, so-called personalized cancer therapy, including biological therapy of tumors. In addition to cancer therapy progress, molecular biology also contributes to identification and characterization of number of biomarkers.
The biomarker is a characteristic biological system feature, which can be objectively measured and used to monitor the state of organism. Molecular biology is looking for new prognostic or predictive biomarkers as well as for biomarkers improving cancer diagnostics using not only molecular genetics but also certain modifications of biochemical serum parameters or immunohistochemical tissue examination.
Dermatooncology follows current trends in oncology and helps to form them in number of cases thus contributing significantly to knowledge and introduction of personalized cancer therapy.